Regencell Bioscience (RGC)
(Real Time Quote from BATS)
$6.75 USD
-0.85 (-11.18%)
Updated Aug 5, 2024 12:36 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
RGC 6.75 -0.85(-11.18%)
Will RGC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RGC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for RGC
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Regencell Bioscience Holdings Ltd trading resumes
Regencell Bioscience Holdings Ltd trading halted, volatility trading pause
Catalyst Watch: Tech blitz with Apple, Amazon, Microsoft, and Meta on tap for earnings